Valuation: Dermapharm Holding SE

Market Cap 2.36B 2.69B 2.17B 2.04B 3.82B 254B 3.9B 26.13B 10.11B 125B 10.1B 9.88B 435B P/E 2026 *
17.9x
P/E 2027 * 16.3x
Enterprise Value 3.15B 3.59B 2.9B 2.72B 5.1B 339B 5.2B 34.9B 13.5B 168B 13.49B 13.2B 581B EV / Sales 2026 *
2.61x
EV / Sales 2027 * 2.39x
Free-Float
10.7%
Yield 2026 *
2.13%
Yield 2027 * 2.36%
1 day+2.26%
1 week+2.26%
Current month-2.36%
1 month-0.94%
3 months+6.97%
6 months+23.64%
Current year+20.97%
1 week 45.85
Extreme 45.85
48
1 month 45.85
Extreme 45.85
49.65
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 2017-07-31
Director of Finance/CFO - 2022-10-31
Investor Relations Contact - 2018-11-30
Director TitleAgeSince
Chairman 70 2017-07-31
Director/Board Member 65 2017-07-31
Director/Board Member 77 2017-12-31
Date Insider Type Main position Quantity % Market Cap.
05-13Buy

Chairman

380,000 0.7670%
01-06Buy 150 0.0003%
01-06Buy 150 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.26%+2.26%+36.98%+7.94% 2.69B
+7.13%+9.97%+51.94%+166.83% 1,077B
+3.99%+11.50%+67.53%+55.63% 613B
+4.20%+17.03%+35.63%+87.74% 448B
+0.99%+4.85%+27.93%+22.82% 332B
+1.82%+8.19%+41.15%+26.80% 293B
+0.22%+6.75%+31.51%+42.02% 286B
+0.73%+8.53%-26.22%-40.85% 215B
+1.56%+6.14%+28.38%+59.45% 193B
+3.26%+3.33%+18.83%+67.03% 159B
Average +2.08%+7.43%+31.37%+49.54% 361.88B
Weighted average by Cap. +2.26%+8.92%+40.51%+81.23%

Financials

2026 *2027 *
Net sales 1.21B 1.38B 1.11B 1.04B 1.96B 130B 2B 13.39B 5.18B 64.26B 5.18B 5.06B 223B 1.25B 1.43B 1.16B 1.08B 2.03B 135B 2.07B 13.9B 5.38B 66.7B 5.37B 5.26B 231B
Net income 139M 159M 128M 120M 225M 14.95B 230M 1.54B 596M 7.39B 595M 582M 25.63B 155M 177M 143M 134M 251M 16.69B 256M 1.72B 665M 8.25B 665M 650M 28.61B
Net Debt 792M 903M 730M 684M 1.28B 85.22B 1.31B 8.78B 3.4B 42.12B 3.39B 3.32B 146B 636M 725M 586M 548M 1.03B 68.38B 1.05B 7.04B 2.72B 33.79B 2.72B 2.66B 117B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
26-06-26 €47.60 +2.26% 11,290
26-06-25 €46.55 -0.85% 12,701
26-06-24 €46.95 +0.86% 11,194
26-06-23 €46.55 0.00% 10,925
26-06-22 €46.55 0.00% 19,316
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
47.60EUR
Average target price
50.38EUR
Spread / Average Target
+5.83%

Quarterly revenue - Rate of surprise